Time to First-Line Antiretroviral Treatment Failure and Its Predictors among HIV-Positive Children in Shashemene Town Health Facilities, Oromia Region, Ethiopia, 2019

With expanding pediatric antiretroviral therapy access, children will begin to experience treatment failure and require second-line therapy. In resource-limited settings, treatment failure is often diagnosed based on the clinical or immunological criteria which occur way after the occurrence of viro...

Full description

Saved in:
Bibliographic Details
Main Authors: Endale Zenebe, Assefa Washo, Abreham Addis Gesese
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2021/8868479
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556906845044736
author Endale Zenebe
Assefa Washo
Abreham Addis Gesese
author_facet Endale Zenebe
Assefa Washo
Abreham Addis Gesese
author_sort Endale Zenebe
collection DOAJ
description With expanding pediatric antiretroviral therapy access, children will begin to experience treatment failure and require second-line therapy. In resource-limited settings, treatment failure is often diagnosed based on the clinical or immunological criteria which occur way after the occurrence of virological failure. Previous limited studies have evaluated immunological and clinical failure without considering virological failure in Ethiopia. The aim of this study was to investigate time to first-line antiretroviral treatment failure and its predictors in Shashamene town health facilities with a focus on virological criteria. Methods. A retrospective cohort study was conducted in three health facilities of Shashamene town, Oromia Regional State, from March 1 to 26, 2019. Children aged less than 15 years living with HIV/AIDS that were enrolled on ART between January 1, 2011, and December 30, 2015, in Shashamene town health facilities were the study population. Data were extracted using a checklist, entered into EpiData version 3.1, and exported to SPSS version 20 for data analysis. Cox proportional hazard regression was used to determine the predictors of time to first-line treatment failure. Result. The median survival time to virological failure was 30 months with IQR of 24.42 to 44.25. Baseline WHO stages 3 and 4 with AHR = 5.69 (95% CI: 2.07–15.66) and NVP-based NNRT at initial treatment with AHR = 2.72 (1.13–6.54) were the independent predictors of time to treatment failure. Conclusion. The median survival time of first-line antiretroviral treatment failure was moderate in the study area as compared to other studies. The incidence density of treatment failure in this study was low as compared to other studies. The finding also demonstrated that children treated with nevirapine-based nonnucleoside reverse transcriptase inhibitors at initial and advanced WHO clinical stages at baseline were at higher risk of treatment failure.
format Article
id doaj-art-9abca55b808d483cb48c820298bc3d85
institution Kabale University
issn 2356-6140
1537-744X
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-9abca55b808d483cb48c820298bc3d852025-02-03T05:44:09ZengWileyThe Scientific World Journal2356-61401537-744X2021-01-01202110.1155/2021/88684798868479Time to First-Line Antiretroviral Treatment Failure and Its Predictors among HIV-Positive Children in Shashemene Town Health Facilities, Oromia Region, Ethiopia, 2019Endale Zenebe0Assefa Washo1Abreham Addis Gesese2Jimma University, College of Public Health and Medical Science, Department of Epidemiology, Jimma, EthiopiaHawassa College of Health Science, Department of Public Health, Hawassa, EthiopiaJimma University, College of Public Health and Medical Science, Department of Epidemiology, Jimma, EthiopiaWith expanding pediatric antiretroviral therapy access, children will begin to experience treatment failure and require second-line therapy. In resource-limited settings, treatment failure is often diagnosed based on the clinical or immunological criteria which occur way after the occurrence of virological failure. Previous limited studies have evaluated immunological and clinical failure without considering virological failure in Ethiopia. The aim of this study was to investigate time to first-line antiretroviral treatment failure and its predictors in Shashamene town health facilities with a focus on virological criteria. Methods. A retrospective cohort study was conducted in three health facilities of Shashamene town, Oromia Regional State, from March 1 to 26, 2019. Children aged less than 15 years living with HIV/AIDS that were enrolled on ART between January 1, 2011, and December 30, 2015, in Shashamene town health facilities were the study population. Data were extracted using a checklist, entered into EpiData version 3.1, and exported to SPSS version 20 for data analysis. Cox proportional hazard regression was used to determine the predictors of time to first-line treatment failure. Result. The median survival time to virological failure was 30 months with IQR of 24.42 to 44.25. Baseline WHO stages 3 and 4 with AHR = 5.69 (95% CI: 2.07–15.66) and NVP-based NNRT at initial treatment with AHR = 2.72 (1.13–6.54) were the independent predictors of time to treatment failure. Conclusion. The median survival time of first-line antiretroviral treatment failure was moderate in the study area as compared to other studies. The incidence density of treatment failure in this study was low as compared to other studies. The finding also demonstrated that children treated with nevirapine-based nonnucleoside reverse transcriptase inhibitors at initial and advanced WHO clinical stages at baseline were at higher risk of treatment failure.http://dx.doi.org/10.1155/2021/8868479
spellingShingle Endale Zenebe
Assefa Washo
Abreham Addis Gesese
Time to First-Line Antiretroviral Treatment Failure and Its Predictors among HIV-Positive Children in Shashemene Town Health Facilities, Oromia Region, Ethiopia, 2019
The Scientific World Journal
title Time to First-Line Antiretroviral Treatment Failure and Its Predictors among HIV-Positive Children in Shashemene Town Health Facilities, Oromia Region, Ethiopia, 2019
title_full Time to First-Line Antiretroviral Treatment Failure and Its Predictors among HIV-Positive Children in Shashemene Town Health Facilities, Oromia Region, Ethiopia, 2019
title_fullStr Time to First-Line Antiretroviral Treatment Failure and Its Predictors among HIV-Positive Children in Shashemene Town Health Facilities, Oromia Region, Ethiopia, 2019
title_full_unstemmed Time to First-Line Antiretroviral Treatment Failure and Its Predictors among HIV-Positive Children in Shashemene Town Health Facilities, Oromia Region, Ethiopia, 2019
title_short Time to First-Line Antiretroviral Treatment Failure and Its Predictors among HIV-Positive Children in Shashemene Town Health Facilities, Oromia Region, Ethiopia, 2019
title_sort time to first line antiretroviral treatment failure and its predictors among hiv positive children in shashemene town health facilities oromia region ethiopia 2019
url http://dx.doi.org/10.1155/2021/8868479
work_keys_str_mv AT endalezenebe timetofirstlineantiretroviraltreatmentfailureanditspredictorsamonghivpositivechildreninshashemenetownhealthfacilitiesoromiaregionethiopia2019
AT assefawasho timetofirstlineantiretroviraltreatmentfailureanditspredictorsamonghivpositivechildreninshashemenetownhealthfacilitiesoromiaregionethiopia2019
AT abrehamaddisgesese timetofirstlineantiretroviraltreatmentfailureanditspredictorsamonghivpositivechildreninshashemenetownhealthfacilitiesoromiaregionethiopia2019